Company intelligence / Profile preview
APstem Therapeutics
Fremont, California, United Statesapstemtx.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
APstem Therapeutics has developed a patented platform based on Adult High Plasticity Stem Cells (AHPSCs), which are derived from human donor blood. These cells exhibit high regenerative capacity and immunocompatibility suitable for allogeneic use. The company’s preclinical data support broad potential in treating diabetes mellitus/type I diabetes, chronic wounds/diabetic foot ulcers, liver injury/disease, alopecia/hair loss/aging skin conditions, and neurodegenerative disorders. No clinical trial results have been published yet; the company remains at the preclinical stage across its pipeline as of early/mid–2025.
- Therapeutic areas
- EndocrinologyImmunologyDermatologyGastroenterologyNeurology
- Modalities
- Stem cell therapy (Adult High Plasticity Stem Cells/AHPSC)ExosomesBiological products
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Exclusive license with Stanford University for foundational IP related to peripheral blood-derived stem cells.
Beyond the preview
Go deeper on APstem Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on APstem Therapeutics.